Liquidia (LQDA) Total Current Liabilities (2019 - 2026)
Liquidia (LQDA) recorded quarterly Total Current Liabilities of $149.7 million in Q1 2026, up 10.29% quarter-over-quarter from $135.8 million in Q4 2025, and up 147.43% on a YoY basis from $60.5 million in Q1 2025.
Liquidia (LQDA) Total Current Liabilities (2019 - 2026) Analysis & Trends
Liquidia's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $149.7 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 147.43% year-over-year to $149.7 million; the TTM figure through Mar 2026 stood at $149.7 million (up 147.43% YoY), while the FY2025 annual figure was $135.8 million, up 224.95% from the prior year.
- Total Current Liabilities was $149.7 million for Q1 2026 at Liquidia, up from $135.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $149.7 million in Q1 2026 to a low of $6.8 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $43.4 million across 5 years, with a median of $21.9 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities retreated 14.49% in 2023, then jumped 224.95% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $8.8 million in 2022, then surged by 110.8% to $18.6 million in 2023, then surged by 125.23% to $41.8 million in 2024, then surged by 224.95% to $135.8 million in 2025, then climbed by 10.29% to $149.7 million in 2026.
- The last three Total Current Liabilities figures came in at $149.7 million (Q1 2026), $135.8 million (Q4 2025), and $102.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 149.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.74 Mn |
| Dec 31, 2025 | 135.77 Mn |
| Sep 30, 2025 | 102.94 Mn |
| Jun 30, 2025 | 78.41 Mn |
| Mar 31, 2025 | 60.52 Mn |
| Dec 31, 2024 | 41.78 Mn |
| Sep 30, 2024 | 33.84 Mn |
| Jun 30, 2024 | 24.22 Mn |
| Mar 31, 2024 | 21.93 Mn |
| Dec 31, 2023 | 18.55 Mn |
| Sep 30, 2023 | 12.16 Mn |
| Jun 30, 2023 | 19.50 Mn |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | 8.80 Mn |
| Sep 30, 2022 | 7.46 Mn |
| Jun 30, 2022 | 6.84 Mn |
| Mar 31, 2022 | 7.98 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Sep 30, 2021 | 7.06 Mn |
| Jun 30, 2021 | 6.97 Mn |